Format

Send to

Choose Destination
See comment in PubMed Commons below
Biotechnol Healthc. 2007 Oct;4(5):49-54.

A Renewed Emphasis on Therapeutic Angiogenesis Research for CAD.

Author information

1
Jack Jacobs, PhD, is chief scientific officer and chief operating officer at CardioVascular BioTherapeutics, in Las Vegas.

Abstract

Up to now, unblocking clogged arteries for so-called no-option patients with coronary artery disease or congestive heart failure hasn't been possible. Angiogenesis research, despite previous setbacks, may be the answer for this group of patients.

PMID:
22478677
PMCID:
PMC2651718
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for PubMed Central
    Loading ...
    Support Center